LFWD and ORMP Related Headlines
Go Back- Lifeward closes strategic partnership with Oramed
- Lifeward Successfully Closes on Strategic Partnership with Oramed
- Lifeward receives shareholder approval for Oramed partnership deal
- Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
- Lifeward enters $47 million strategic partnership with Oramed
- Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
- Oramed to transfer drug delivery tech to Lifeward for 49.9% stake
- Oramed and Lifeward Announce Strategic Transaction
LFWD and ORMP Related Press Releases
Go Back- Lifeward Successfully Closes on Strategic Partnership with Oramed
- Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
- Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
- Oramed and Lifeward Announce Strategic Transaction
